Bioresorbable vascular scaffold (BVS) is a nonmetallic mesh tube, which is used to treat blocked arteries. It is similar to a stent but gradually dissolves once the blocked artery starts functioning naturally again, enabling the artery to return to its natural state. The scaffold disappears in around 12-24 months and supports the vessel until it gain its full function. BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. It is used by patients who are suffering from different types of cardiovascular diseases. Some of the commonly used BVS for cardiac procedures include Poly-L-Lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffold, and hybrid bioresorbable scaffold.
Market Dynamics
Increasing demand for bioresorbable vascular scaffold owing to high prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to drive market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death in the world, accounting for over 17.9 million deaths per year globally, and this number is expected to increase to over 23.6 million by 2030. From the same source, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. in 2015, which is about 1 of every 3 deaths.
Moreover, key players are opting for different strategies such as new product launches, FDA approvals, partnerships, and collaborations to increase its foothold in the market. For instance, in July 2016, Abbott received the U.S. Food and Drug Administration approval for Absorb bioresorbable heart stent. This device is first-of-its-kind medical device with fully dissolving heart stents. This device will be available to treat people with coronary artery disease in the U.S.
However, preference for vascular graft devices for angioplasty and coronary artery diseases is one of the major factors restraining growth of the global bioresorbable vascular scaffold market. Furthermore, stringent regulatory scenario has also obstructed growth of the market.
Key features of the study:
- This report provides in-depth analysis of the bioresorbable vascular scaffold market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles leading players in the global bioresorbable vascular scaffold market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun Melsungen AG, and Terumo Corporation among others
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global bioresorbable vascular scaffold market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for bioresorbable vascular scaffold market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Bioresorbable Vascular Scaffold Market, By Product Type:
- Global Bioresorbable Vascular Scaffold Market, By Material Type:
- Metal based BVS
- Polymer based BVS
- Global Bioresorbable Vascular Scaffold Market, By Application
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- Global Bioresorbable Vascular Scaffold Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- Global Bioresorbable Vascular Scaffold Market, By Geography:
- North America
- By Product Type:
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- Latin America
- By Product Type:
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abbott Laboratories*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Cook Medical
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Medtronic Plc
- Stentys SA
- MAQUET Holding B.V. & Co. KG (Getinge AB)
- W.L. Gore & Associates
- C. R. Bard, Inc.,
- Theragenics Corporation
“*” marked represents similar segmentation in other categories in the respective section.
